NCT06363526

Brief Summary

The purpose of this study is to analyze the effectiveness of a 5-weeks respiratory digital intervention program in patients with Duchenne muscular dystrophy and Becker muscular dystrophy.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 12, 2024

Completed
10 months until next milestone

Study Start

First participant enrolled

February 5, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

6 months

First QC Date

March 22, 2024

Last Update Submit

March 26, 2025

Conditions

Keywords

Duchenne Muscular DystrophyBecker Muscular DystrophyBreathing exercisesInspiratory muscle trainingPulmonary rehabilitationExpiratory muscle training

Outcome Measures

Primary Outcomes (1)

  • Analyze the improvement of the forced vital capacity (FVC).

    Forced vital capacity is a respiratory parameter which is obtained from spirometry and which provides objective, valid information. It will be performed using spirometry before and after the digital respiratory intervention program. The spirometer that will be used is the "EasyOne Air Spirometer that complies with ISO 26782 standards, following the national spirometric recommendations of the ATS/ERS 2019.

    Baseline, up to 5 weeks.

Secondary Outcomes (10)

  • Perform an anthropometric study of the patient's characteristics, taking into account weight; and also a general physical examination.

    Baseline, up to 5 weeks.

  • Perform an anthropometric study of the patient's characteristics, taking into account age.

    Baseline, up to 5 weeks.

  • Perform an anthropometric study of the patient's characteristics, taking into account height.

    Baseline, up to 5 weeks.

  • Perform an anthropometric study of the patient's characteristics, taking into account sex.

    Baseline, up to 5 weeks.

  • Examine changes in forced expiratory pressure

    Baseline, up to 5 weeks.

  • +5 more secondary outcomes

Study Arms (1)

Patients with Duchenne muscular dystrophy and Becker muscular dystrophy

EXPERIMENTAL

A group of 12 patients with Duchenne muscular dystrophy and Becker muscular dystrophy that will be following a digital respiratory physiotherapy program.

Other: Digital respiratory intervention program

Interventions

A 4 times a week for a period of 5 weeks will be done, for a duration of 55-60 minutes (20 sessions), with an intensity adapted to the characteristics of each participant. Moreover, an intervention program will be used based on respiratory muscle training exercises, upper limb strength work, yoga, diaphragmatic awareness exercises, always trying to do them through the use of games, and even try to include exercises that use motor imagery. The intervention program is carried out and stimulated through videos and therapeutic teaching to the caregivers in the first evaluation session, as well as as well as with a weekly follow-up using WhatsApp or Zoom as forms of communication, or a telephone call to ensure correct follow-up of the intervention program. Moreover, YouTube videos, own videos prepared by the physiotherapy will be used to help optimally resolve doubts that arise when carrying out the program by video call.

Patients with Duchenne muscular dystrophy and Becker muscular dystrophy

Eligibility Criteria

Age5 Years - 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Participants with Duchenne muscular dystrophy and patients with Becker muscular dystrophy will be chosen.
  • Aged between 5 and 20 years.
  • Child who could walk and follow the intervention program, and were diagnosed according to the International Classification of Diseases, 10 Revision. code (G71-01); and who had an NSSA score greater than 20.

You may not qualify if:

  • Patients who present associated heart disease.
  • Patients who presentor fractures, a heart rate greater than 120 beats per minute, or an oxygen saturation less than 89% will be excluded.
  • Participants who do not have the capacity to have internet at home to perform the intervention, as well as all patients whose caregivers did not agree to sign the informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rocío Martín-Valero

Málaga, Spain

Location

MeSH Terms

Conditions

Muscular Dystrophy, DuchenneMuscular Dystrophies

Condition Hierarchy (Ancestors)

Muscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Rocío Martín-Valero, PhD

    University of Malaga

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: 12 participants were randomized to follow a digital respiratory physiotherapy program for 5 weeks. The participants were evaluated at the beginning and at the end of the study, and the results will be measured before and after each intervention during the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 22, 2024

First Posted

April 12, 2024

Study Start

February 5, 2025

Primary Completion

July 30, 2025

Study Completion

December 30, 2025

Last Updated

April 1, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations